Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(05):584–90.ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Tanaka N, Kaczynska D, Kanatani S, Sahlgren C, Mitura P, Stepulak A, Miyakawa A, Wiklund P, Uhlen P. Mapping of the three-dimensional lymphatic microvasculature in bladder tumours using light-sheet microscopy. Br J Cancer. 2018;118(7):995–9.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chen JJ, Wang SJ, Tsai CA, Lin CJ. Selection of differentially expressed genes in microarray data analysis. Pharmacogenomics J. 2007;7(3):212–20.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Mahin KF, Robiuddin Md, Islam M, Ashraf S, Yeasmin F, Shatabda S. PanClassif improving pan cancer classification of single cell RNA-Seq gene expression data using machine learning. Genomics. 2022;114(2): 110264.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hossain SM, Khatun L, Ray S, Mukhopadhyay A. Pan-cancer classification by regularized multi-task learning. Sci Rep. 2021;11(1):24252.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Khadirnaikar S, Shukla S, Prasanna SR. Integration of pan-cancer multi-omics data for novel mixed subgroup identification using machine learning methods. PLoS ONE. 2023;182023(10): e0287176.ArticleÂ
Google ScholarÂ
Petrini I, Meltzer PS, Kim I-K, Lucchi M, Park K-S, Fontanini G, Gao J, Zucali PA, Calabrese F, Favaretto A, Rea F, Rodriguez-Canales J, Walker RL, Pineda M, Zhu YJ, Lau C, Killian KJ, Bilke S, Voeller D, Dakshanamurthy S, Wang Y, Giaccone G. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet. 2014;46(8):844–9.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Snezhkina AV, Lukyanova EN, Zaretsky AR, Kalinin DV, Pokrovsky AV, Golovyuk AL, Krasnov GS, Fedorova MS, Pudova EA, Kharitonov SL, Melnikova NV, Alekseev BY, Kiseleva MV, Kaprin AD, Dmitriev AA, Kudryavtseva AV. Novel potential causative genes in carotid paragangliomas. BMC Med Genet. 2019;20(Suppl 1):48.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lesluyes T, Baud J, Pérot G, Charon-Barra C, You A, Valo I, Bazille C, Mishellany F, Leroux A, Renard-Oldrini S, Terrier P, Cesne AL, Laé M, Piperno-Neumann S, Bonvalot S, Neuville A, Collin F, Maingon P, Coindre J-M, Chibon F. Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas. Mod Pathol Off J US Can Acad Pathol. 2019;32(12):1786–94.CASÂ
Google ScholarÂ
Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nat Methods. 2012;9(4):357–9.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liao Y, Smyth GK, Shi W. featurecounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–30.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A, Szcześniak MW, Gaffney DJ, Elo LL, Zhang X. A survey of best practices for RNA-Seq data analysis. Genome Biol. 2016;17(1):1–19.
Google ScholarÂ
Dillies M-A, Rau A, Aubert J, Hennequet-Antier C, Jeanmougin M, Servant N, Keime C, Marot G, Castel D, Estelle J. A comprehensive evaluation of normalization methods for illumina high-throughput RNA sequencing data analysis. Brief Bioinform. 2013;14(6):671–83.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Zhao S, Ye Z, Stanton R. Misuse of RPKM or TPM normalization when comparing across samples and sequencing protocols. RNA. 2020;26(8):903–9.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhao Y, Li M-C, Konaté MM, Chen L, Das B, Chris Karlovich P, Williams M, Evrard YA, Doroshow JH, McShane LM. TPM, FPKM, or normalized counts? A comparative study of quantification measures for the analysis of RNA-Seq data from the NCI patient-derived models repository. J Transl Med. 2021;19(1):269.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mohamed A, Graves A, Hinton G. Speech recognition with deep recurrent neural networks. In: IEEE international conference on acoustics, speech and signal processing; 2013. p. 6645–9Pierre B, Sadowski Peter J. Understanding dropout. In: Advances in neural information processing systems; 2013. vol. 26, p. 2814–22.Huang H, Li D, Zhang Z, Chen X, Huang K. Adversarially occluded samples for person re-identification. In: Proceedings of the IEEE conference on computer vision and pattern recognition; 2018. p. 5098–5107.Zeiler MD, Fergus R. Visualizing and understanding convolutional networks. In: Computer vision-ECCV 2014: 13th European conference, Zurich, Switzerland, September 6–12, 2014, Proceedings, Part I 13. Springer; 2014. p. 818–33Mostavi M, Chiu YC, Huang Y, Chen Y. Convolutional neural network models for cancer type prediction based on gene expression. BMC Med Genomics. 2020;13(Suppl 5):44.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
de Guia JM, Devaraj M, Leung CK. DeepGX: deep learning using gene expression for cancer classification. In: Proceedings of the 2019 IEEE/ACM international conference on advances in social networks analysis and mining; 2019. p. 913–20.Khalifa NE, Taha MH, Ali DE, Slowik A, Hassanien AE. Artificial intelligence technique for gene expression by tumor RNA-Seq data: a novel optimized deep learning approach. IEEE Access. 2020;8:22874–83.ArticleÂ
Google ScholarÂ
Zhao Y, Pan Z, Namburi S, Pattison A, Posner A, Balachander S, Paisie CA, Reddi HV, Rueter J, Gill AJ, Fox S, Raghav KPS, Flynn WF, Tothill RW, Li S, Karuturi RKM, George J. CUP-AI-Dx: a tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence. EBioMedicine. 2020;61: 103030.ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sun K, Wang J, Wang H, Sun H. Genect: a generalizable cancerous status and tissue origin classifier for pan-cancer biopsies. Bioinformatics. 2018;34(23):4129–30.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Fan F, Chen D, Zhao Y, Wang H, Sun H, Sun K. Rapid preliminary purity evaluation of tumor biopsies using deep learning approach. Comput Struct Biotechnol J. 2020;18:1746–53.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kim SK, Kim SY, Kim JH, Roh SA, Cho DH, Kim YS, Kim JC. A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients. Mol Oncol. 2014;8(8):1653–66.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Schug J, Schuller WP, Kappen C, Salbaum JM, Bucan M, Stoeckert CJ Jr. Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol. 2005;6(4):R33.ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kadota K, Ye J, Nakai Y, Terada T, Shimizu K. Roku: a novel method for identification of tissue-specific genes. BMC Bioinform. 2006;7:294.ArticleÂ
Google ScholarÂ
Camargo AP, Vasconcelos AA, Fiamenghi MB, Pereira GAG, Carazzolle MF. Tspex: a tissue-specificity calculator for gene expression data. Res Square; 2020.Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Asplund A, Sjöstedt E, Lundberg E, Szigyarto CA, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, Nilsson P, Schwenk JM, Lindskog C, Danielsson F, Mardinoglu A, Sivertsson A, von Feilitzen K, Forsberg M, Zwahlen M, Olsson I, Navani S, Huss M, Nielsen J, Ponten F, Uhlén M. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteom. 2014;13(2):397–406.ArticleÂ
CASÂ
Google ScholarÂ
van Bodegraven EJ, van Asperen JV, Robe PAJ, Hol EM. Importance of GFAP isoform-specific analyses in astrocytoma. Glia. 2019;67(8):1417–33.ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Duff MO, Olson S, Wei X, Garrett SC, Osman A, Bolisetty M, Plocik A, Celniker SE, Graveley BR. Genome-wide identification of zero nucleotide recursive splicing in drosophila. Nature. 2015;521(7552):376–9.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, Hasz R, Walters G, Garcia F, Young N, Foster B, Moser M, Karasik E, Gillard B, Ramsey K, Sullivan S, Bridge J, Magazine H, Syron J, Fleming J, Siminoff L, Traino H, Mosavel M, Barker L, Jewell S, Rohrer D, Maxim D, Filkins D, Harbach P, Cortadillo E, Berghuis B, Turner L, Hudson E, Feenstra K, Sobin L, Robb J, Branton P, Korzeniewski G, Shive C, Tabor D, Qi L, Groch K, Nampally S, Buia S, Zimmerman A, Smith A, Burges R, Robinson K, Valentino K, Bradbury D, Cosentino M, Diaz-Mayoral N, Kennedy M, Engel T, Williams P, Erickson K, Ardlie K, Winckler W, Getz G, DeLuca D, MacArthur D, Kellis M, Thomson A, Young T, Gelfand E, Donovan M, Meng Y, Grant G, Mash D, Marcus Y, Basile M, Liu J, Zhu J, Tu Z, Cox NJ, Nicolae DL, Gamazon ER, Im HK, Konkashbaev A, Pritchard J, Stevens M, Flutre T, Wen X, Dermitzakis ET, Lappalainen T, Guigo R, Monlong J, Sammeth M, Koller D, Battle A, Mostafavi S, McCarthy M, Rivas M, Maller J, Rusyn I, Nobel A, Wright F, Shabalin A, Feolo M, Sharopova N, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580–5.ArticleÂ
CASÂ
Google ScholarÂ
Pontén F, Jirström K, Uhlen M. The human protein atlas—a tool for pathology. J Pathol J Pathol Soc Great Br Ireland. 2008;216(4):387–93.
Google ScholarÂ
Cai H, An Y, Chen X, Sun D, Chen T, Peng Y, Zhu F, Jiang Y, He X. Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2. Oncotarget. 2016;7(52):86857.ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mulong D, Shi D, Yuan L, Li P, Chu H, Qin C, Yin C, Zhang Z, Wang M. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep. 2015;5(1):10437.ArticleÂ
Google ScholarÂ
Hong S, Yan Z, Wang H, Ding L, Song Y, Bi M. miR-663b promotes colorectal cancer progression by activating RAS/RAF signaling through downregulation of TNK1. Hum Cell. 2020;33(1):104–15.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Luo XF, Wu XJ, Wei X, Wang AG, Wang SH, Wang JL. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma. Eur Rev Med Pharmacol Sci. 2019;23(20):8751–60.PubMedÂ
Google ScholarÂ
Jiang HY, Wang ZJ. ADPGK-AS1 promotes the progression of colorectal cancer via sponging miR-525 to upregulate FUT1. Eur Rev Med Pharmacol Sci. 2020;24(5):2380–6.PubMedÂ
Google ScholarÂ
Song S, Weihua Yu, Lin S, Zhang M, Wang T, Guo S, Wang H. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Cancer Biol Therapy. 2018;19(7):573–83.ArticleÂ
CASÂ
Google ScholarÂ
Yang J, Weizhu W, Minhua W, Ding J. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/otx1 axis in breast cancer. In Vitro Cel Dev Biol Anim. 2019;55(7):522–32.ArticleÂ
CASÂ
Google ScholarÂ
Song J, Peng J, Zhu C, Bai G, Liu Y, Zhu J, Liu J. Identification and validation of two novel prognostic LncRNAs in kidney renal clear cell carcinoma. Cell Physiol Biochem. 2018;48(6):2549–62.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Yang L, Yang T, Wang H, Dou T, Fang X, Shi L, Li X, Feng M. DNMBP-AS1 regulates NHLRC3 expression by sponging miR-93-5p/17-5p to inhibit colon cancer progression. Front Oncol. 2022;12: 765163.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liu Z, Lam N, Thiele CJ. Zinc finger transcription factor CASZ1 interacts with histones, DNA repair proteins and recruits NuRD complex to regulate gene transcription. Oncotarget. 2015;6(29):27628–40.ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kwak S, Kim TW, Kang B-H, Kim J-H, Lee J-S, Lee H-T, Hwang I-Y, Shin J, Lee J-H, Cho E-J, Youn H-D. Zinc finger proteins orchestrate active gene silencing during embryonic stem cell differentiation. Nucleic Acids Res. 2018;46(13):6592–607.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Cassandri M, Smirnov A, Novelli F, Pitolli C, Agostini M, Malewicz M, Melino G, Raschellá G. Zinc-finger proteins in health and disease. Cell Death Discov. 2017;3(1):1–12.ArticleÂ
Google ScholarÂ
Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, Sanli K, von Feilitzen K, Oksvold P, Lundberg E, Hober S, Nilsson P, Mattsson J, Schwenk JM, Brunnström H, Glimelius B, Sjöblom T, Edqvist P-H, Djureinovic D, Micke P, Lindskog C, Mardinoglu A, Ponten F. A pathology atlas of the human cancer transcriptome. Science. 2017;357(6352):eaan2507.ArticleÂ
PubMedÂ
Google ScholarÂ
Uhlén M, Björling E, Agaton C, Al-Khalili Szigyarto C, Amini B, Andersen E, Andersson A-C, Angelidou P, Asplund A, Asplund C, Berglund L, Bergström K, Brumer H, Cerjan D, Ekström M, Elobeid A, Eriksson C, Fagerberg L, Falk R, Fall J, Forsberg M, Björklund MG, Gumbel K, Halimi A, Hallin I, Hamsten C, Hansson M, Hedhammar M, Hercules G, Kampf C, Larsson K, Lindskog M, Lodewyckx W, Lund J, Lundeberg J, Magnusson K, Malm E, Nilsson P, Ödling J, Oksvold P, Olsson I, Öster E, Ottosson J, Paavilainen L, Persson A, Rimini R, Rockberg J, Runeson M, Sivertsson Ã…, Sköllermo A, Steen J, Stenvall M, Sterky F, Strömberg S, Sundberg M, Tegel H, Tourle S, Wahlund E, Waldén A, Wan J, Wernérus H, Westberg J, Wester K, Wrethagen U, Xu LL, Hober S, Pontén F. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cel Proteom. 2005;4(12):1920–32.ArticleÂ
Google ScholarÂ
Heyliger SO, Soliman KFA, Saulsbury MD, Renee RR. Prognostic relevance of ZNF844 and Chr 19p13 2 KRAB-zinc finger proteins in clear cell renal carcinoma. Cancer Genom Proteom. 2022;19(3):305–27.ArticleÂ
CASÂ
Google ScholarÂ
Wang W, Zhijian X, Wang N, Yao R, Qin T, Lin H, Yue L. Prognostic value of eight immune gene signatures in pancreatic cancer patients. BMC Med Genom. 2021;14(1):42.ArticleÂ
CASÂ
Google ScholarÂ
Yan W, Scoumanne A, Jung Y-S, Xu E, Zhang J, Zhang Y, Ren C, Sun P, Chen X. Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation. Genes Dev. 2016;30(5):522–34.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Hibino E, Hiroaki H. Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy. Biophys Rev. 2022;14(1):267–75.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Farnebo M, Bykov VJN, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun. 2010;396(1):85–9.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Jiang H, Cheng L, Hu P, Liu R. MicroRNA-663b mediates TAM resistance in breast cancer by modulating TP73 expression. Mol Med Rep. 2018;18(1):1120–6.CASÂ
PubMedÂ
Google ScholarÂ
Howell A, Howell SJ. Tamoxifen evolution. Br J Cancer. 2023;128(3):421–5.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang M, Jia M, Yuan K. MicroRNA-663b promotes cell proliferation and epithelial mesenchymal transition by directly targeting SMAD7 in nasopharyngeal carcinoma. Exp Ther Med. 2018;16(4):3129–34.PubMedÂ
PubMed CentralÂ
Google ScholarÂ
You X, Wang Y, Meng J, Han S, Liu L, Sun Y, Zhang J, Sun S, Li X, Sun W, Dong Y, Zhang Y. Exosomal miR-663b exposed to TGF-ß1 promotes cervical cancer metastasis and epithelial-mesenchymal transition by targeting MGAT3. Oncol Rep. 2021;45(4):1.ArticleÂ
Google ScholarÂ
Guo L, Li B, Miao M, Yang J, Ji J. MicroRNA-663b targets GAB2 to restrict cell proliferation and invasion in hepatocellular carcinoma. Mol Med Rep. 2019;19(4):2913–20.CASÂ
PubMedÂ
Google ScholarÂ
Yang F, Liu Y, Dong S, Ma R, Bhandari A, Zhang X, Wang O. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer. Biochem Biophys Res Commun. 2016;470(3):479–83.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Jin Y, Zhang M, Duan R, Yang J, Yang Y, Wang J, Jiang C, Yao B, Li L, Yuan H, Zha X, Ma C. Long noncoding RNA FGF14-AS2 inhibits breast cancer metastasis by regulating the miR-370-3p/FGF14 axis. Cell Death Discov. 2020;6(1):1–14.ArticleÂ
Google ScholarÂ
Hou R, Liu Y, Yanzhuo S, Shu Z. Overexpression of long non-coding RNA FGF14-AS2 inhibits colorectal cancer proliferation via the RERG/Ras/ERK signaling by sponging microRNA-1288-3p. Pathol Oncol Res. 2020;26(4):2659–67.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Li R, Chen Y, Wu J, Cui X, Zheng S, Yan H, Wu Y, Wang F. LncRNA FGF14-AS2 represses growth of prostate carcinoma cells via modulating miR-96-5p/AJAP1 axis. J Clin Lab Anal. 2021;35(11): e24012.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC, et al. David bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(suppl–2):W169–75.ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Shibel R, Sarfstein R, Nagaraj K, Lapkina-Gendler L, Laron Z, Dixit M, Yakar S, Werner H. The olfactory receptor gene product, OR5H2, modulates endometrial cancer cells proliferation via interaction with the IGF1 signaling pathway. Cells. 2021;10(6):1483.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Weber L, Schulz WA, Philippou S, Eckardt J, Ubrig B, Hoffmann MJ, Tannapfel A, Kalbe B, Gisselmann G, Hatt H. Characterization of the olfactory receptor or10h1 in human urinary bladder cancer. Front Physiol. 2018;9:456.ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bose S, Banerjee S, Mondal A, Chakraborty U, Pumarol J, Croley CR, Bishayee A. Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy. Cells. 2020;9(6):1451.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xiao-Jie L, Ai-Mei G, Li-Juan J, Jiang X. Pseudogene in cancer: real functions and promising signature. J Med Genet. 2015;52(1):17–24.ArticleÂ
PubMedÂ
Google ScholarÂ
Pan Y, Sun C, Huang M, Liu Y, Qi F, Liu L, Wen J, Liu J, Xie K, Ma H, Hu Z, Shen H. A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma. J Biomed Res. 2014;28(3):194–200.ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006;38(4):431–40.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Han L, Yuan Y, Zheng S, Yang Y, Li J, Edgerton ME, Diao L, Xu Y, Verhaak RGW, Liang H. The pan-cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat Commun. 2014;5:3963.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ